Screening and Early Detection — MCQs
Which of the following statements are true? 1. Due to increasing mammography there occurs over diagnosis of breast carcinoma 2. Colon cancer screening is done by digital rectal examination 3. Oral cancer screening is done by visual inspection 4. Cervix cancer screening is done by a pap smear
Which of the following statements about screening for disease is false?
What is the correct formula for calculating the positive predictive value (PPV) of a screening test?
The following cost-effective investigations are routinely recommended in the screening of antenatal mothers, EXCEPT:
According to the U.S. Preventive Services Task Force (USPSTF) guidelines, what is the recommended age to begin routine screening mammography for average-risk women?
Which of the following statements about screening tests is correct?
Gold standard investigation for breast carcinoma screening in a patient with silicone breast implants
A 37-year-old unmarried nulliparous woman, having regular intercourse, is on oral contraceptive pills. Her mother was diagnosed with carcinoma breast at 60 years of age, and her elder sister was diagnosed with carcinoma ovary at 40 years of age. What is the next line of management?
A resource-limited setting shows high rates of congenital syphilis despite antenatal screening programs. Lab records show stock-outs and delayed results. Which integrated approach is most cost-effective?
Screening is not useful in which carcinoma
Screening and Early Detection Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following statements are true? 1. Due to increasing mammography there occurs over diagnosis of breast carcinoma 2. Colon cancer screening is done by digital rectal examination 3. Oral cancer screening is done by visual inspection 4. Cervix cancer screening is done by a pap smear
- A. 1,2,3,4
- B. 4 only
- C. 1,3,4 (Correct Answer)
- D. 2,3,4
Explanation: ***Correct: 1,3,4*** - **Statement 1 is TRUE**: Overdiagnosis is a well-documented consequence of increased mammography screening. It detects slow-growing tumors that might never have caused clinical symptoms or harm during a woman's lifetime, leading to unnecessary treatment and associated morbidities. - **Statement 3 is TRUE**: Oral cancer screening primarily involves thorough visual inspection by a healthcare professional to identify suspicious lesions, ulcers, or color changes in the oral cavity. - **Statement 4 is TRUE**: Cervical cancer screening is effectively done by Pap smear, which detects precancerous and cancerous cells. - **Statement 2 is FALSE**: Digital rectal examination is NOT the primary screening method for colon cancer. Standard screening methods include colonoscopy, fecal occult blood testing (FOBT), and fecal immunochemical test (FIT). *Incorrect: 1,2,3,4* - While statements 1, 3, and 4 are true, statement 2 is incorrect. Digital rectal examination is not a primary or definitive screening method for colon cancer—it only examines the rectum and misses most of the colon. *Incorrect: 4 only* - While cervical cancer screening by Pap smear is true, this option is incomplete as it misses other true statements (1 and 3) regarding mammography overdiagnosis and oral cancer screening. *Incorrect: 2,3,4* - This option incorrectly includes statement 2. Colon cancer screening is NOT done by digital rectal examination. Proper screening methods include colonoscopy, FOBT, FIT, and flexible sigmoidoscopy.
Question 2: Which of the following statements about screening for disease is false?
- A. Time consuming
- B. Arbitrary and final (Correct Answer)
- C. Rarely a basis for starting treatment without further confirmation
- D. Done on apparently healthy people
Explanation: ***Arbitrary and final*** ✓ **FALSE Statement - Correct Answer** - Screening tests are **NOT arbitrary** - they use **established diagnostic criteria**, validated cutoff points, and standardized protocols - Screening is **NOT final** - positive screening results always require **confirmatory diagnostic tests** before treatment decisions - This statement is false because screening follows **evidence-based protocols** and serves as a **preliminary step** in disease detection, not a definitive diagnosis *Time consuming* - TRUE Statement - Mass screening programs are indeed **time-consuming** due to large population coverage, scheduling logistics, and follow-up requirements - The process includes **participant recruitment**, **test administration**, **result notification**, and **tracking** of screen-positive individuals *Rarely a basis for starting treatment without further confirmation* - TRUE Statement - Screening tests are designed to **identify high-risk individuals** who require further evaluation, not to make treatment decisions - **Confirmatory diagnostic tests** with higher specificity are required before initiating treatment - Starting treatment based solely on screening results risks **overdiagnosis** and **unnecessary interventions** in false-positive cases *Done on apparently healthy people* - TRUE Statement - Screening specifically targets **asymptomatic populations** to detect disease in **preclinical stages** - The goal is **early detection** before symptoms appear, when intervention may be most effective - Distinguishes screening from diagnostic testing, which is performed on symptomatic individuals
Question 3: What is the correct formula for calculating the positive predictive value (PPV) of a screening test?
- A. True positives / (True positives + False negatives)
- B. False positives / (False positives + True negatives)
- C. True positives / (True positives + False positives) (Correct Answer)
- D. True negatives / (True negatives + False negatives)
Explanation: ***True positives / (True positives + False positives)*** - **Positive predictive value (PPV)** indicates the probability that a patient who tests positive actually has the disease. - It is calculated by dividing the number of **true positives** (correctly identified positive cases) by the total number of positive test results (**true positives + false positives**). *True positives / (True positives + False negatives)* - This formula represents the **sensitivity** of a test, which is the proportion of actual positive cases that are correctly identified. - Sensitivity measures the ability of a test to correctly identify individuals with the disease. *False positives / (False positives + True negatives)* - This formula represents **1 - specificity**, or the **false positive rate**. - **Specificity** is the proportion of actual negative cases that are correctly identified as negative. *True negatives / (True negatives + False negatives)* - This formula represents the **negative predictive value (NPV)**, which is the probability that a patient who tests negative actually does not have the disease. - NPV is calculated by dividing the number of **true negatives** (correctly identified negative cases) by the total number of negative test results (**true negatives + false negatives**).
Question 4: The following cost-effective investigations are routinely recommended in the screening of antenatal mothers, EXCEPT:
- A. Blood sugar levels for GDM
- B. VDRL for syphilis
- C. Urine analysis for bacteriuria
- D. Echocardiography for cardiac disease (Correct Answer)
Explanation: ***Echocardiography for cardiac disease*** - **Echocardiography** is not a *routinely recommended* screening investigation for all antenatal mothers due to its cost and the relatively low prevalence of significant congenital heart disease requiring universal screening. - It is typically performed only if there are **specific risk factors** or suspicious findings suggesting cardiac pathology. *Blood sugar levels for GDM* - Screening for **gestational diabetes mellitus (GDM)** with blood sugar levels (e.g., glucose challenge test) is routinely recommended due to the potential maternal and fetal complications if untreated. - GDM is a common condition that can be effectively managed with early diagnosis, making screening a **cost-effective** preventive measure. *VDRL for syphilis* - Screening for **syphilis** using tests like VDRL (Venereal Disease Research Laboratory) is a standard and *routinely recommended* antenatal investigation. - Early detection and treatment of syphilis in pregnant women prevent serious adverse outcomes such as **congenital syphilis**, which can cause severe fetal morbidity and mortality. *Urine analysis for bacteriuria* - **Urine analysis** for **asymptomatic bacteriuria** is routinely recommended during pregnancy because untreated bacteriuria can lead to pyelonephritis, preterm labor, and low birth weight. - It is a simple, **cost-effective** test with significant benefits for maternal and fetal health.
Question 5: According to the U.S. Preventive Services Task Force (USPSTF) guidelines, what is the recommended age to begin routine screening mammography for average-risk women?
- A. 30 years
- B. 40 years
- C. 20 years
- D. 50 years (Correct Answer)
Explanation: ***50 years*** - The **USPSTF recommends** starting biennial (every two years) screening mammography for women of **average risk** at age **50 years** (Grade B recommendation). - This recommendation balances the benefits of early cancer detection against the potential harms of false positives and unnecessary interventions in younger women. *30 years* - This age is **too early** for routine screening mammography in average-risk women according to most major guidelines, including the USPSTF. - Screening at this age could lead to a higher rate of **false positives** and associated anxiety and unnecessary follow-up procedures without significant mortality benefit. *40 years* - While some organizations, like the **American Cancer Society (ACS)**, recommend women begin screening at age 40, the USPSTF specifically advises against routine screening before age 50 for average-risk women due to a less favorable **risk-benefit profile**. - **Individualized decision-making** is considered for women aged 40-49, weighing personal values and potential benefits/harms. *20 years* - **No major health organization** recommends routine screening mammography for average-risk women at this age. - Breast tissue is typically **denser** in younger women, making mammographic interpretation more difficult and less effective, and the incidence of breast cancer is very low.
Question 6: Which of the following statements about screening tests is correct?
- A. Sensitivity is 1 - False negative rate (Correct Answer)
- B. Sensitivity is 1 - False positive rate
- C. Post-test probability is only influenced by pre-test probability
- D. None of the options is correct.
Explanation: ***Sensitivity is 1 - False negative rate*** - **Sensitivity** refers to the proportion of **true positive results** among all individuals with the disease. - The **false negative rate** is the proportion of individuals with the disease who test negative, so **1 - false negative rate** correctly defines sensitivity. *Sensitivity is 1 - False positive rate* - The false positive rate (1 - specificity) is related to the proportion of individuals without the disease who test positive. - This statement incorrectly defines sensitivity, confusing it with concepts related to specificity. *Post-test probability is only influenced by pre-test probability* - **Post-test probability** is influenced by both the **pre-test probability** and the **likelihood ratio** of the diagnostic test. - The **likelihood ratio** incorporates the test's sensitivity and specificity, making it a critical factor in modifying the probability of disease after testing. *None of the options is correct.* - The first statement, "Sensitivity is 1 - False negative rate," is a correct definition of sensitivity.
Question 7: Gold standard investigation for breast carcinoma screening in a patient with silicone breast implants
- A. Mammography
- B. CT scan
- C. USG
- D. MRI (Correct Answer)
Explanation: ***MRI*** - **MRI** is considered the **gold standard** for breast cancer screening in patients with silicone breast implants due to its superior ability to visualize breast tissue through the implant and detect subtle lesions. - It offers **high sensitivity** in detecting both implant rupture and early malignancies, often providing better clarity than mammography in augmented breasts where implants can obscure tissue. *Mammography* - While a standard screening tool, **mammography** can be limited in patients with silicone implants because the implants can **obscure adjacent breast tissue**, making detection of small masses challenging. - Special views (e.g., **Eklund views**) can be used, but sensitivity is still reduced compared to MRI in augmented breasts. *CT scan* - **CT scans** are not routinely used for primary breast cancer screening due to their use of **ionizing radiation** and lower sensitivity for detecting early breast lesions compared to MRI. - CT is more commonly used for **staging** advanced cancers or evaluating complex masses detected by other modalities. *USG* - **Ultrasound (USG)** is a valuable complementary tool, especially for evaluating palpable lumps or clarifying findings from mammography, but it is **operator-dependent** and has a lower overall sensitivity for general screening compared to MRI. - It is particularly useful for differentiating between **cystic and solid masses** and detecting implant ruptures but is not the gold standard for comprehensive screening in augmented breasts.
Question 8: A 37-year-old unmarried nulliparous woman, having regular intercourse, is on oral contraceptive pills. Her mother was diagnosed with carcinoma breast at 60 years of age, and her elder sister was diagnosed with carcinoma ovary at 40 years of age. What is the next line of management?
- A. Prophylactic surgery
- B. Stop taking oral contraceptive pills
- C. Routine mammography
- D. Genetic counseling and screening for BRCA (Correct Answer)
Explanation: ***Genetic counseling and screening for BRCA*** - The patient's family history is highly suggestive of a **hereditary breast and ovarian cancer (HBOC) syndrome**, specifically a BRCA gene mutation. - **Sister with ovarian cancer at age 40** is a major red flag—ovarian cancer at ≤50 years in a first-degree relative is a specific criterion for BRCA testing according to NCCN guidelines. - Additionally, the mother's breast cancer (even at 60) combined with the sister's early ovarian cancer creates a **two first-degree relatives with breast/ovarian cancer pattern** that further strengthens the indication for genetic testing. - **Genetic counseling** is essential to assess risk, discuss testing options, interpret results, and plan appropriate risk-reduction strategies. - BRCA1/2 mutations confer a **40-60% lifetime risk of ovarian cancer** and **70-80% lifetime risk of breast cancer**. *Prophylactic surgery* - **Risk-reducing bilateral salpingo-oophorectomy (RRSO)** and possibly bilateral mastectomy are important options for BRCA mutation carriers, but should only be considered **after** genetic counseling and confirmed identification of a pathogenic mutation. - Proceeding directly to surgery without genetic confirmation would be premature and potentially unnecessary. *Stop taking oral contraceptive pills* - **OCPs actually reduce ovarian cancer risk** by approximately 50% with long-term use, which is protective even in BRCA carriers. - While OCPs may have a minimal impact on breast cancer risk, the ovarian cancer risk reduction benefit generally outweighs this concern. - Stopping OCPs without further genetic risk assessment is not the appropriate next step. *Routine mammography* - Standard mammography screening is insufficient for high-risk individuals with likely BRCA mutations. - If BRCA mutation is confirmed, enhanced screening protocols are recommended: **annual MRI plus mammography starting at age 30**, or 10 years before the earliest breast cancer in the family. - The priority is genetic assessment first to determine if intensified screening is warranted.
Question 9: A resource-limited setting shows high rates of congenital syphilis despite antenatal screening programs. Lab records show stock-outs and delayed results. Which integrated approach is most cost-effective?
- A. Implementation of point-of-care testing with same-day treatment (Correct Answer)
- B. Enhanced partner notification only
- C. Universal prophylactic treatment
- D. Increased lab capacity with result tracking system
Explanation: ***Implementation of point-of-care testing with same-day treatment*** - This approach directly addresses **stock-outs** and **delayed results** by providing immediate diagnosis and treatment, significantly reducing the window for mother-to-child transmission. - **Point-of-care testing (POCT)** eliminates the need for complex lab infrastructure and transport, making it highly cost-effective and efficient in resource-limited settings. *Enhanced partner notification only* - While important for controlling syphilis spread, **partner notification alone** does not solve the fundamental issues of delayed diagnosis and treatment for the pregnant woman. - It would not prevent congenital syphilis in cases where the mother's infection is already established and untreated due to diagnostic delays. *Universal prophylactic treatment* - Administering **universal prophylactic treatment** without a confirmed diagnosis is not cost-effective due to unnecessary drug use, potential for antibiotic resistance, and wastage of resources. - It would also not address the underlying systemic issues of screening program failures, only providing a broad, untargeted intervention. *Increased lab capacity with result tracking system* - This option addresses **delayed results** and **stock-outs** but requires significant financial investment in infrastructure, equipment, and personnel, which may not be feasible or as rapid in implementation as POCT. - Even with increased capacity, transport of samples and results can still introduce delays, and the cost-benefit might be lower compared to immediate POCT.
Question 10: Screening is not useful in which carcinoma
- A. Testicular carcinoma (Correct Answer)
- B. Carcinoma prostate
- C. Carcinoma colon
- D. Carcinoma breast
Explanation: Testicular carcinoma - **Testicular cancer** typically presents as a painless mass, and **self-examination** is often emphasized for early detection rather than formal screening programs due to low incidence and variable benefits. - While early detection is important, population-wide screening for testicular cancer is **not recommended** due to its rarity and lack of evidence for improved outcomes compared to opportunistic detection. *Carcinoma prostate* - **Prostate cancer screening** using **PSA (prostate-specific antigen)** testing and digital rectal examinations is routinely performed, though its benefits and risks are debated [1]. - Early detection aims to identify potentially aggressive cancers, but also leads to **overdiagnosis and overtreatment** of indolent lesions [1]. *Carcinoma colon* - **Colorectal cancer screening** is highly effective and widely recommended through methods like **colonoscopy**, fecal occult blood testing, and sigmoisingoscopy. - Screening aims to detect **polyps** before they become cancerous or find cancer at an early, treatable stage, significantly reducing mortality. *Carcinoma breast* - **Breast cancer screening** using **mammography** is a well-established and highly effective method for early detection in women. - Early detection allows for timely treatment, significantly improving prognosis and reducing breast cancer mortality.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free